![](https://cancer.uillinois.edu/wp-content/uploads/2022/03/Gadi-Onclive-2-23-22-featured.png)
SABCS 2021: Small Molecule Clinical Trials in R/R HER2+ mBC
Rounding out their conversation on SABCS 2021, Dr. VK Gadi and experts discuss small molecule-based treatment strategies for relapsed/refractory HER2+ metastatic breast cancer.
![](https://cancer.uillinois.edu/wp-content/uploads/2021/08/OncLive_2013_SAP_Seal.jpg)
The University of Illinois Cancer Center serves as a Strategic Alliance Partner with OncLive. View our complete video library.